010-60605840
结构式搜索
  1. 首页
  2. 产品目录
  3. Signaling Pathways(信号通路)
  4. GPCR/G Protein
  5. CXCR
中文名称: NBI-74330
英文名称: NBI-74330
CAS No: 855527-92-3
分子式: C32H27F4N5O3
分子量: 605.58
安全技术说明书(PDF) MSDS(PDF) 点击下载产品说明书(PDF)
N10716 NBI-74330 ≥98% (psaitong)
包装规格：
5mg in glass bottle
溶解性：
溶于DMSO（100mg/mL 超声）
产品描述：

基本信息

产品编号：

N10716 

产品名称：

NBI-74330

CAS:

855527-92-3

 

储存条件

粉末

-20℃

四年

 

 

分子式：

C32H27F4N5O3

溶于液体

-80℃

6个月

分子量：

605.58

-20℃

1个月

化学名： 

N-{1-[3-(4-Ethoxyphenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl]ethyl}-2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-(3-pyridinyl methyl)acetamide

Solubility (25°C)：

 

体外:

 

DMSO

 

Ethanol

 

Water

 

体内(现配现用):

 

＜1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得，实际溶液度可能与公布值有所偏差，属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；⼀旦配成溶液，请分装保存，避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

1.6513mL

8.2565mL

16.5131mL

5mM

0.3303mL

1.6513mL

3.3026mL

10mM

0.1651mL

0.8257mL

1.6513mL

 

生物活性

产品描述

一种有效的 CXCR3 拮抗剂，能够抑制 (125I)CXCL10 和 (125I)CXCL11 的特异性结合，Ki 值分别为 1.5 和 3.2nM。

靶点

125I]CXCL10-CXCR3 1.5nM (Ki,in CXCR3-CHO cell membranes)

[125I]CXCL11-CXCR3 3.2nM (Ki,in CXCR3-CHO cell membranes)

 

体外研究

BI-74330 demonstrates potent inhibition of [125I]CXCL11 specific binding to membranes prepared from transfected CHO cells expressing CXCR3 (CXCR3-CHO) (Ki=3.6nM).NBI-74330 is 12- and 3.5-fold more potent than CXCL9 (Ki=45.2nM) and CXCL10 (Ki=12.5nM),respectively,at inhibiting [125I]CXCL11 binding to CXCR3-CHO cell membranes.NBI-74330 inhibits calcium mobilization in response to CXCL11 and CXCL10 with an IC50 value of 7nM for both ligands used at their EC80 concentrations (1nM for CXCL11 and 30nM for CXCL10).NBI-74330 specifically inhibits CXCR3-mediated calcium mobilization.NBI-74330 also dose-dependently inhibits CXCL11-induced [35S]GTPγS binding in membranes of cells endogenously expressing CXCR3 (H9 cells,IC50 value 5.5nM).BI-74330 inhibits CXCL11-induced chemotaxis in these cells with an IC50 of 3.9nM.BI-74330 (30-300nm,1-10μM) produces concentration-dependent,parallel rightward shifts of the CXCL11 E/[A] curve with no significant change in the E/[A] curve maximal response.

体内研究

NBI-74330 (100mg/kg) results in the formation of an N-oxide metabolite,also an antagonist of CXCR3,in mice.Mice treated with 100mg/kg NBI-74330 (in 1% Na Doc in 0.5% 400Cp Methylcellulose) result in serum concentrations of approximately 1μM.This concentration is sufficient to fully block the CXCR3 receptor in vivo.

 

推荐实验方法(仅供参考)

激酶实验：

Cell membrane fractions are resuspended in 50mM HEPES,10mM MgCl2,100mM NaCl,and 1mM CaCl2,pH 7.2 for use in competitive radioligand binding reactions.Reactions are performed in duplicate and consisted of 25-μL unlabeled chemokine at indicated concentrations,25-μL radiolabeled chemokine ligand (appr 70nM;[125I]CXCL11 and [125I]CXCL10 with specific activities of 1500 and 2200 Ci/mmol,respectively;Fifty-μL membrane protein (5μg) are added sequentially in assay buffer (50mM HEPES,10mM MgCl2,100mM NaCl,1mM CaCl2,and 0.1% BSA,pH 7.2) to low-binding 96-well plates.The reaction is allowed to reach equilibrium by incubation at room temperature for 45 min while shaking.The amount of bound radioligand is determined by harvesting membranes via filtration through a UniFilter GF/C filter plate using a UniFilter-96 vacuum manifold (filters are pretreated with 1% polyethylenimine), washing twice with 400-μL wash buffer (10mM HEPES,5mM MgCl2,1mM CaCl2,and 500mM NaCl,pH 7.3),and measuring radioactivity by liquid scintillation using a TopCount NXT.The dissociation half-life of [125I]CXCL11 is measured using CXCR3-CHO membranes that are allowed to equilibrate with radiolabel (appr 70nM) for 30 min prior to the addition of excess cold CXCL11 (31nM final) in the presence or absence of different concentrations of NBI-74330.Membrane-bound [125I]CXCL11 is assessed in duplicate along with nonspecific binding ([125I]CXCL11 plus excess cold CXCL11 added at the same) and total binding ([125I]CXCL11 without inhibitors) at each time point on the same plate.

 

动物实验:

 

Female LDLr−/−mice,10 weeks old (n=8 to 12 per group),are fed a Western-type diet containing 0.25% cholesterol and 15% cocoa butter 2 weeks before collar placement.20 Mice are treated with a subcutaneous injection of 100mg/kg NBI-74330 every day during the entire experiment.After 8 weeks of Western-type diet and treatment,the mice are euthanized and organs are harvested for histology,fluorescence-activated-cell sorter (FACS) analysis,and RNA isolation.Blood samples are collected by tail bleeding from nonfasted animals,and concentrations of serum cholesterol and triglycerides are determined using enzymatic colorimetric procedures.
保存条件：
-20℃
UN码：
HazardClass：
危害声明：
安全说明：
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为：
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量，填写另外两个变量

用本工具协助配置特定浓度的溶液，使用的计算公式为：
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为：C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
购物指南
参考资料
支付方式
关于配送
售后服务
微信二维码
首页 |网站使用条款 |隐私政策 |关于我们 |营业执照 |结构式搜索
© 2001-2020 北京普西唐生物科技有限公司  天津普西唐生物医药科技有限公司
版权所有，并保留所有权利 
备案号：京ICP备17064988号-1